Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Oct 16, 2021

Later deadlines: Nov 16, 2021, Jan 7, 2022

Grant amount: Up to US $275,000

Fields of work: Human Genome & Genetics

Applicant type: Organizations

Funding uses: Behavioral

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: Applications are due by 5 p.m. submitter's local time.

The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that examines the role of telomeres in wellness and disease, and to advance the incorporation of telomere studies into biobehavioral programs of research. A body of research has demonstrated the contribution of telomeres to health-related outcomes; however, additional studies are needed to achieve the full potential for incorporating telomere-guided approaches for maintaining wellness, reducing the risk and burden of disease, and for advancing symptom and self-management strategies.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed November 26, 2018 and last updated November 26, 2018